Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAD001 in Chinese Adults With Progressive Pancreatic Neuroendocrine Tumors
CTR20160035Phase 4Completed
- Sponsor
- Novartis
- Start
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of everolimus in islet cell tumor, sponsored by Novartis. Started Mar 2016; status: completed.
02
Drugs
everolimus
03
Conditions
islet cell tumor
Beyond the preview
Go deeper on CTR20160035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160035.